Status:
UNKNOWN
Factors Predicting Erythropoietin Responsiveness in Children on Hemodialysis at Sohag University Hospital
Lead Sponsor:
Sohag University
Conditions:
Pediatric Patients on Hemodialysis
Eligibility:
All Genders
1+ years
Brief Summary
Anemia is common in patients on hemodialysis (HD) due to lack of erythropoietin (EPO) synthesis and iron deficiency is occurring in HD patients due to chronic blood loss through the dialysis circuit, ...
Eligibility Criteria
Inclusion
- (1) patients started dialysis in the age range of 1-18years. (2) Patient will be on regular hemodialysis.
Exclusion
- Children who have no other co existent hematological disorder .
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05312346
Start Date
April 1 2022
End Date
April 1 2023
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University Hospital
Sohag, Egypt